Nanotechnology Now - Press Release: CombiMatrix to Present At Invest Northwest 2009 Conference

Home > Press > CombiMatrix to Present At Invest Northwest 2009 Conference

Abstract:
CombiMatrix Corporation (Nasdaq:CBMX) today announced Dr. Amit Kumar, President and CEO, will present at the Invest Northwest(tm) 2009 Conference on March 18, 2009, at 10:10 a.m. (PDT), in the Bay Auditorium at the Bell Harbor International Conference Center located in Seattle, Washington.

CombiMatrix to Present At Invest Northwest 2009 Conference

MUKILTEO, WA | Posted on March 7th, 2009

To listen to the live audio webcast of Dr. Kumar's presentation, please go to www.wsw.com/webcast/in7/cbmx/. You may also listen to the webcast by going to CombiMatrix's website at investor.combimatrix.com/events.cfm. The webcast will be archived for 90 days following the live presentation.

Invest Northwest 2009 is the region's premier life sciences investment conference, where public and private life science companies tell their stories to institutional investors, analysts, investment bankers, fund managers, venture capitalists, angel investors, and prospective corporate partners. Learn more and register at www.investnorthwest.org.

####

About CombiMatrix Corporation
CombiMatrix Corporation is a diversified biotechnology business that develops proprietary technologies, including products and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology and defense and homeland security markets, as well as in other potential markets where our products and services could be utilized. The technologies we have developed include a platform technology to rapidly produce user-defined, in-situ synthesized, oligonucleotide arrays for use in identifying and determining the roles of genes, gene mutations and proteins. This technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology. Other technologies include proprietary molecular synthesis and screening methods for the discovery of potential new drugs. Combimatrix Molecular Diagnostics, Inc. ("CMDX"), our wholly owned subsidiary located in Irvine, California, has developed capabilities of producing arrays that utilize bacterial artificial chromosomes, which also enable genetic analysis. CMDX functions primarily as a diagnostics reference laboratory.

Additional information about CombiMatrix Corporation is available at www.combimatrix.com or by calling 1-800-985 CBMX (2269). Additional information about CMDX is available at www.cmdiagnostics.com or by calling 1-800-710-0624.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory, and competitive developments, and general economic conditions. Our Annual Report on Form 10-K, recent and forthcoming Quarterly Reports on Form 10-Q, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations, and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

For more information, please click here

Contacts:
Lazar Partners
Media Contact:
Mark Sahl
(646) 871-8485

CombiMatrix Corporation
Investor Relations Contact:
Amit Kumar, Ph.D., President & CEO
(425) 493-2000
Fax: (425) 493-2010

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: